2018

ICABELL, a new boost to the internationalization of IDIBELL’s research

Leave a Comment / Uncategorised / By

The Bellvitge Biomedical Research Institute has been awarded 176,734€ in order to carry out the “ICABELL – Internationalization of biomedical research on the Bellvitge Campus” project, whose main researcher is Dr. Josep Manuel Menchón. The aid is part of the Call for Boosting Actions: Europe Networks and Managers – Europe Technology Centers 2017, which is […]

ICABELL, a new boost to the internationalization of IDIBELL’s research Read More »

Nobel Laureate Erwin Neher visits IDIBELL

Leave a Comment / Neuropharmacology and pain , Neuroscience Program / By

The winner of the 1991 Nobel Prize for Medicine visits the institute and talks to its younger researchers Last Wednesday, February 21st, the Bellvitge Biomedical Research Institute (IDIBELL) welcomed professor Erwin Neher, Nobel Prize in Physiology or Medicine in 1991, to participate in an informal meeting with the pre and postdoctoral researchers of the institute.

Nobel Laureate Erwin Neher visits IDIBELL Read More »

RAC1 protein could be a new therapeutic target to fight neurodegeneration in Parkinson’s disease

Leave a Comment / Neuroscience Program, Stem Cell Potency  / By

A new research study reveals RAC1 protein could be a new therapeutic target to study the molecular mechanisms related to the neurodegenerative processes in Parkinson’s disease. The study, published in the online edition of the journal Molecular Neurobiology, is led by Antonella Consiglio, researcher at the Faculty of Medicine and Health Sciences of the University of Barcelona, the

RAC1 protein could be a new therapeutic target to fight neurodegeneration in Parkinson’s disease Read More »

Scientists prove the implication of an amino acid transporter in age-related deafness

Leave a Comment / Genes, Disease and Therapy Program, Human Molecular Genetics, Traslacional Medicine / By

The CIBERER U730 and U731 units, led respectively by Virginia Nunes (IDIBELL, UB) and Manuel Palacín (IRBB, UB) have just published in eLife a study carried out in collaboration with the U761 units (Isabel Varela-Nieto, CSIC / UAM) and U716 (Mara Dierssen, CRG), as well as with international groups, Dr. Meritxell Espino (Sidra Medicine, Qatar) and Dr.

Scientists prove the implication of an amino acid transporter in age-related deafness Read More »

The IT-LIVER European consortium expands TGF-beta knowledge in liver cancer

Leave a Comment / Cancer, Nutrition, metabolism and Gene Therapy , TGF-beta and cancer / By

The research of the TGF-beta and cancer group of the Bellvitge Biomedical Research Institute (IDIBELL) within the IT-LIVER (Inhibiting TGF-beta in liver diseases) consortium, a collaborative European action coordinated by Dr. Isabel Fabregat, has led to three new impact publications that offer new insights into the molecular mechanisms associated with the cytokine TGF-beta in liver

The IT-LIVER European consortium expands TGF-beta knowledge in liver cancer Read More »

Àlex Vaquero is awarded 200,000 euros from Worldwide Cancer Research to better understand the origin of cancer

Leave a Comment / Chromatine biology / By

Dr. Àlex Vaquero, leader of the chromatin biology research group of the Bellvitge Biomedical Research Institute (IDIBELL), has been awarded one of the prestigious grants from the Worldwide Cancer Research organization,  worth 200,000 euros. The grant will fund a new project of this basic research group focused on the study of the mechanisms of tumor

Àlex Vaquero is awarded 200,000 euros from Worldwide Cancer Research to better understand the origin of cancer Read More »

The Cátedra Extraordinaria del Dolor honors Francisco Ciruela for the design of the first photoactive drug with analgesic action

Leave a Comment / Neuropharmacology and pain , Neuroscience Program / By

Professor Francisco Ciruela, from the Faculty of Medicine and Health Sciences of the University of Barcelona, the Institute of Neurosciences of the UB and the Bellvitge Biomedical Research Institute (IDIBELL), has been awarded the Preclinical Research Award from Cátedra Extraordinaria del Dolor of the University of Salamanca – Grünenthal Foundation. This prize awards a research with animal models, published in the

The Cátedra Extraordinaria del Dolor honors Francisco Ciruela for the design of the first photoactive drug with analgesic action Read More »

Successful first #Lindibell swing jam for biomedical research

Leave a Comment / Sin categorizar / By

Last Saturday, January 27th, the Casino of the Center of l’Hospitalet hosted the first Lindibell charity swing jam, the benefits of which will be used to fund some activitites for the young researchers from the Bellvitge Biomedical Research Institute of Bellvitge (IDIBELL). In this first edition, the initiative has raised € 550 thanks to the

Successful first #Lindibell swing jam for biomedical research Read More »

Researchers identify a new NF-kB pathway regulatory mechanism linked to SirT6

Leave a Comment / Cancer, Chromatine biology / By

Researchers from the Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Àlex Vaquero, have proposed a new regulation mechanism of the NF-κB pathway, which is associated with accelerated cellular aging, based on the analysis of the function of the SirT6 protein. The results of their work, published in

Researchers identify a new NF-kB pathway regulatory mechanism linked to SirT6 Read More »

Scroll to Top